International medical tourism from the Netherlands for gene therapy

The Netherlands Commission on Genetic Modification (COGEM) commisioned a study to the scope and nature of medical tourisme of patients from the Netherlands in the field of gene therapy.

The study was carried out by Schenkelaars Biotechnology Consultancy, and was aimed at resolving two key questions:

1. What is the scope of patients from the Netherlands who have travelled and travel abroad for treatment with experimental or registered (approved) gene therapy products?
2. What has been or is the nature of the treatments with experimental or registered (approved) gene therapy products received by patients from the Netherlands?